Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients Micofenolato mofetil pode proteger contra a pneumonia por Pneumocystis carinii em transplantados renais

• Published in: Revista do Instituto de Medicina Tropical de São Paulo
• Main Authors: Luiz Sergio Azevedo, Maria Cristina R. Castro, Flavio J. Paula, Luiz Estevam Ianhez, Elias David-Neto
• Format: Article in Journal/Newspaper
• Language: English
• Published: Universidade de São Paulo (USP) 2005
• Subjects: Kidney transplantation; Mycophenolate mofetil; Pneumocystis carinii; Pneumonia; Immunosuppression; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216; Arctic; Sob’
• Online Access: https://doi.org/10.1590/S0036-46652005000300005; https://doaj.org/article/bb543d2dada14b7593e477ae432c1af0

Pneumocystis carinii pneumonia (PCP) is usually prevented in transplanted patients by prophylactic trimethoprim-sulfamethoxazol (TMS). Mycophenolate mofetil (MMF) has been shown to have a strong protective effect against PCP in rats. This effect is also suggested in humans by the absence of PCP in p...